UnitedHealth Group's Q1 2013 earnings show strong revenue growth across all segments, driven by Optum's strong performance.  Management highlighted continued organic growth and market share gains, with pricing yielding as expected.  However, the significant reduction in Medicare Advantage funding for 2014 is a major headwind, potentially impacting membership and earnings in the coming year.
[1]
